Follow up for Positive COVID 19 Cases and their Close Contacts - - PowerPoint PPT Presentation

follow up for positive covid 19 cases and their close
SMART_READER_LITE
LIVE PREVIEW

Follow up for Positive COVID 19 Cases and their Close Contacts - - PowerPoint PPT Presentation

Follow up for Positive COVID 19 Cases and their Close Contacts Tools for LBOHs July 7, 2020 Hillary Johnson, MHS, Infectious Disease Epidemiologist Scott Troppy, MPH, PMP, CIC, Surveillance Epidemiologist Bureau of Infectious Disease and


slide-1
SLIDE 1

Follow‐up for Positive COVID‐19 Cases and their Close Contacts

Tools for LBOHs

Hillary Johnson, MHS, Infectious Disease Epidemiologist Scott Troppy, MPH, PMP, CIC, Surveillance Epidemiologist Bureau of Infectious Disease and Laboratory Sciences MA Department of Public Health

July 7, 2020

slide-2
SLIDE 2

Topics Today

  • MAVEN Updates
  • MAVEN Online Status Map
  • MAVEN On‐Call & Help Desk Stats
  • Vital Records and COVID‐19 as Cause of

Death

  • These cases are created as ‘probable’ if no

lab is obtained.

  • Updated Testing Guidance is Here! (July 3)
  • Repeat PCR+ Cases and Next Steps
  • An evolving guidance
  • Your Questions!

2

slide-3
SLIDE 3

MAVEN Updates On‐Call Help Desk Statistics

Reed Sherrill, Surveillance Epidemiologist Scott Troppy, Surveillance Epidemiologist Bureau of Infectious Disease and Laboratory Sciences MA Department of Public Health

As of 7/7/2020

slide-4
SLIDE 4

Updates for today, Tuesday, 7/7

  • MAVEN Status Map – one town to go
  • MAVEN On‐Call and Email Statistics
  • LBOH Immediate Workflow – COVID‐19 event only
  • Staff updates – please email isishelp@state.ma.us if any

staff needs to be removed from MAVEN. If users have not logged into MAVEN in 30 days their accounts will be deactivated and a retraining will have to take place.

4

slide-5
SLIDE 5

MAVEN Status Map as of 7/7/2020

5

slide-6
SLIDE 6

MAVEN User Requests & Training 3/1/2020 ‐ 6/30/2020

Status Count N ew Users (added week of 7/6/2020)

10

In Training

32

Trained Users

958

Total New Users Trained Or In Process

1000

Total System (MAVEN) Users

1,527

*these data is accurate as of 7/06/2020 at 8:30PM. New Users = Received user requests and forwarded to the VG for user account creation (2 day process) In Training = The VG account has been created and waiting on MAVEN Training (Mondays from 11‐12:30) Trained Users = Trained internal and external staff with VG MAVEN accounts created and MAVEN accounts created by ISIS staff and then access granted appropriate access Total System (MAVEN) Users = Includes MDPH, LBOH, Infection Prevention and other trained staff

6

slide-7
SLIDE 7

MAVEN On‐Call Events 6/1/2020 – 6/30/2020

Program Area Count Division of Global Populations

10

Epidemiology

351

Immunization (COVID‐19)

995

Informatics and Surveillance (ISIS)

218

Total On‐Call MAVEN Events

1,574

*these data is accurate as of 7/06/2020 at 8:30PM

7

slide-8
SLIDE 8

MAVEN On‐Call Events 3/1/2020 – 6/30/2020

Program Area Count Division of Global Populations

29

Epidemiology Program

1,121

Immunization Program (COVID‐19)

19,011

Informatics and Surveillance (ISIS)

943

Total On‐Call MAVEN Events

21,104

*these data is accurate as of 7/06/2020 at 8:30PM

8

slide-9
SLIDE 9

Year Total On‐Call Events Created

2015 6,739 2016 12,830 2017 12,605 2018 9,296 2019 10,652 So far in 2020 23,699

Pre‐COVID‐19 MAVEN On‐Call Volume

*these data is accurate as of 7/06/2020 at 8:30PM

9

slide-10
SLIDE 10

Questions and Requests received through isishelp@state.ma.us 3/15/2020 – 6/30/2020

Month Count

March 2,383 April 7,816 May 6,403 June 6,602 Total Emails received 23,204

*these data is accurate as of 7/06/2020 at 8:30PM

10

slide-11
SLIDE 11

Immediate Notification workflow (COVID‐19 Only)

  • UPDATE: COVID‐19 Immediate Notification Workflow
  • This will allow proper notification of all new COVID‐19 events

for your jurisdiction.

  • Please review all events/cases in this workflow and complete

your Step 1‐ LBOH Notification to “Yes” to clear out this workflow.

  • If you are retaining ownership then complete Steps 2

(Investigation Started) & 3 (LBOH Investigator (name, lboh, phone number)

  • When you are done then complete Steps 4 (CRF Complete) & 5

(Final Review)

11

slide-12
SLIDE 12

MAVEN Help Section

12

slide-13
SLIDE 13

Tuesday Webinars Going Forward

  • Isolation of Cases and Quarantine of Contacts is

the goal until that strategy changes/evolves.

  • MAVEN is the main reporting source and where

you should document your work.

  • Send Cases to CTC for follow‐up if not:
  • Hospitalized, Deceased, or linked to a Cluster

Facility

  • Focusing on Priority Activities
  • Clusters in Facilities in your community need

your help.

  • Call Epi Program to create cluster events.

Tuesdays @ 11am will continue in July

MAVEN Help has Guidance Documents and Previous Webinars: http://www.maventrainingsite.com/maven‐help/toc.html

MDPH Epi Program: 617‐983‐6800 MDPH MAVEN Help Desk: isishelp@state.ma.us MDPH Food Protection Program: 617‐983‐6712 CTC Help Desk: 857‐305‐2828 COVID19CommunityTracingCollaborativeQuestions@mass.gov 13

slide-14
SLIDE 14

Summary of Key Guidance & Tools

  • Date: July 3, 2020 ‐ Testing of Persons with Suspect COVID‐19
  • Updated Testing Guidance saying who should be tested.
  • Includes language stating we should test CONTACTS to COVID‐19 right away.
  • Still states antibody testing needs more data.
  • BUT, if you ARE going to get serology (antibody) testing, get a PCR at the same time.
  • Date: June 1, 2020 ‐ COVID‐19 PCR and Antibody Testing Public Health Response Recommendations
  • Table describes different Public Health Actions based upon different testing results.
  • Big take home: For serology positive individuals, ask about recent symptoms. Those individuals should be isolated and their

contacts quarantined. Serology positive but no recent symptoms do not require further public health follow‐up at this time.

  • Date: May 11, 2020 ‐ Recommendation for Routine Molecular Testing of People Identified as Close Contacts to

COVID‐19 Cases

  • Recommendation to Test Contacts identified through contact tracing – regardless of symptoms.
  • They still need to isolate a full quarantine period, even if their test comes back negative early in quarantine.
  • Date: May 7, 2020 – Occupational Exposure & Return to Work Guidance
  • HCW & Non‐HCW discontinuation of Isolation Guidance.
  • Describes strategies for ending isolation for cases.
  • Also outlines requirements for quarantine for contacts
  • (While there are two documents (HCW & non‐HCW), the key table on the front page is identical and tells key information)

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download https://www.mass.gov/doc/notification‐to‐test‐contacts‐regardless‐of‐symptoms‐0/download

http://www.maventrainingsite.com/maven‐help/pdf/Serology%20Interpretation%20for%20LBOH_ver3.0_June1.pdf https://www.mass.gov/doc/healthcare‐personnel‐occupational‐exposure‐return‐to‐work‐ guidance/download https://www.mass.gov/doc/non‐healthcare‐workers‐occupational‐exposure‐return‐to‐work‐guidance/download

14

slide-15
SLIDE 15

Vital Records & COVID‐19 Related Deaths

  • Vital records without matching labs in MAVEN that have COVID listed as a

cause of death are considered probable cases.

  • These cases have been imported on an ‘irregular’ basis to try and cut

down on duplicate reporting.

  • Now that vital records ID is in MAVEN, it is easier to identify records that

have not matched.

  • We will be creating these cases more regularly and in a more timely way.
  • What do LBOH need to do:
  • If it is a recent death due to COVID (<2 weeks old), it should be treated as a case and

close contacts should be identified

  • If it is an old event (which should happen less often) no follow up is necessary
  • Update any data or notes if you have them.
  • You can mark CRF completed = No.

15

slide-16
SLIDE 16

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19
  • Guidance about appropriate use of laboratory

testing for COVID‐19.

  • No MAJOR Changes from May guidance, but

some clarifications

  • Individuals should be tested for presence of the

virus using a molecular diagnostic test such as PCR:

  • Symptomatic Individuals
  • Close Contacts
  • Admissions to Healthcare Facilities
  • Asymptomatic Individuals (as recommended)
  • Previous cases with new symptoms

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download 16

slide-17
SLIDE 17

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

COVID‐19 Testing for current infection:

  • To evaluate individuals for current infection, a molecular diagnostic test to

detect the presence of the virus by polymerase chain reaction (PCR) or

  • ther nucleic acid amplification methodology is preferred.
  • Molecular Test like PCR is Preferred
  • A second method to detect the presence of viral proteins is a diagnostic

antigen test. Although the newer diagnostic antigen tests are faster to run, they are less sensitive and a negative antigen test result still requires a molecular test to confirm a negative result due to their decreased sensitivity

  • Antigen Tests are fast but may miss some positives.
  • Negative Antigen Test needs a PCR test for follow‐up.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

17

slide-18
SLIDE 18

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Close Contacts of COVID Cases:

  • All individuals in Massachusetts identified as a

close contacts should be tested. A Local Board

  • f Health, the Massachusetts Department of

Public Health, the Community Tracing Collaborative, or a healthcare provider can recommend testing of a close contact.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

Yes! The Testing Guidance recommends Close Contacts Get Tested, regardless of current symptoms. *NOTE: Contacts that test NEGATIVE must still complete their full 14 day quarantine period. 18

slide-19
SLIDE 19

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Recommended timing of testing for close contacts:

  • Close contacts with any symptom associated with COVID‐19 should be tested
  • promptly. Testing should occur at any time during the contact’s 14‐day quarantine

period, even if the person previously had a negative test result within that same period.

  • Close contacts without symptoms should be tested as soon as possible after they are

notified of their exposure to COVID‐19. The contact is required to quarantine for the full 14 days, even following a negative test result.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

Yes! The Testing Guidance recommends Close Contacts Get Tested, regardless of current symptoms. *NOTE: Contacts that test NEGATIVE must still complete their full 14 day quarantine period. 19

slide-20
SLIDE 20

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Admission to a Healthcare Facility:

  • All individuals should be tested upon admission to a healthcare facility, including but not limited

to, a hospital operated or licensed by the Department of Public Health or Mental Health, long‐ term acute care hospital, or skilled nursing facility.

Asymptomatic Individuals:

  • Asymptomatic individuals not identified as close contacts can be recommended for diagnostic

testing at the direction of their healthcare provider, the Department of Public Health or a state agency, or a local Board of Health. Testing generally requires a clinician’s order and asymptomatic individuals are strongly encouraged to contact their insurer to confirm coverage.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

20

slide-21
SLIDE 21

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Serology Testing:

  • Antibody tests may demonstrate whether an individual was previously infected

with SARS‐CoV‐2 and antibody testing is important to help understand how many people in a population have been exposed to the virus. However, antibody tests are rarely indicated for diagnostic purposes in adults.

  • They may be part of a testing algorithm for PRIMS investigations.
  • In order to be appropriately interpreted, more data are needed on the performance

characteristics of these tests, the immune response to COVID‐19, the timing and duration of antibody response, and how antibodies correlate to protective immunity.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

21

slide-22
SLIDE 22

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Serology Testing:

  • If an antibody test is performed, it is recommended that healthcare providers
  • rder a molecular diagnostic test at the same time.
  • At this time, antibody testing should not be used to guide release from

isolation or for return to work purposes and are rarely indicated for diagnostic purposes.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

22

slide-23
SLIDE 23

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Previously Positive Individual Cleared from Isolation:

  • Previous PCR+ Confirmed Cases may continue to test PCR+ for several weeks.
  • This does not correlate with continuing to be infectious towards others.
  • Once cleared from isolation by either the symptom‐based or test‐based strategy,

retesting is not recommended for the next 6 weeks.

  • These individuals are also not subject to quarantine during this period (<6 wks

after recovery).

  • New exposures >6 weeks after recovery require quarantine

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

23

slide-24
SLIDE 24

Updated Testing Guidance (Diagnostic Testing & Serology Guidance) for Providers is here!

  • Date: July 3, 2020
  • RE: Testing of Persons with Suspect COVID‐19

Previously Positive Individual Cleared from Isolation who Develops NEW SYMPTOMS:

  • Until further data are available, individuals who were previously diagnosed

with COVID‐19, are more than 6 weeks past their release from isolation, and who develop clinically compatible symptoms, should be retested.

  • At this time, these individuals should be retested.
  • If viral RNA is detected by PCR testing, the patient should be isolated and

considered to be re‐infected.

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

*NOTE: New PCR+ test results >6 weeks after recovery require new isolation (again).

24

slide-25
SLIDE 25

Updated Testing Guidance (PCR & Serology) for Providers is here!

  • July 3 Updated Testing Guidance:
  • Direct link to PDF:
  • https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

25

slide-26
SLIDE 26

Previous Positives and New Labs

  • Q. How might we identify a new +PCR in a previously confirmed case that
  • riginally tested PCR positive & recovered >6 weeks ago?
  • A. We do not yet have a good way to identify these situations automatically in

MAVEN, however if you identify them and have questions on follow‐up, please let us know.

  • An extra new lab created a new event instead of appending to the old event.
  • Email ISIS to merge the two events.
  • You may simply notice the new lab.
  • Someone may have brought it to your attention (the case, provider, etc.)
  • MDPH is working on a more automated identification system. More to come on that.

26

slide-27
SLIDE 27

Previous Positives and New Labs: Interview Guidance

For LBOHs who identify previously confirmed cases with new +PCRs >6‐8 weeks after their initial recovery:

  • We want to know :
  • Why was this person tested again?
  • Did they have new symptoms? (What are they? When was the new onset?)
  • Did they have any new known exposures?
  • What types of activities do they engage in that could have led to an unknown exposure?
  • How well do they adhere to mask wearing and social distancing?
  • Put all relevant new clinical information in notes for now.

Interview this Patient 27

slide-28
SLIDE 28

Previous Positives and New Labs: Isolation Guidance

Instructions for Isolation in Previously PCR+ individuals with new PCR+ labs >6 weeks after recovery:

  • Isolation is likely required out of an abundance of caution in most situations:
  • If patient is symptomatic and you think this could be a new infection, the patient should
  • isolate. Call 617‐983‐6800 if you have any questions on case management.
  • If the patient had NO new symptoms and the testing was not due to possible new exposure or

suspicion of new illness, the patient should still isolate at this time for 10 days following date of

  • test. Call 617‐983‐6800 if you have any questions on case management.
  • Possible Exception to be determined on a case by case basis: If the person has persistently tested PCR

positive throughout regular testing in the 6‐8 weeks following initial recovery, they continue to be asymptomatic, and have no indication of new exposures or illness, they may not need to isolate at this

  • time. Call 617‐983‐6800 if you have any questions on case management.
  • This is evolving and recommendations will change as we learn more about the likelihood

and possibility of reinfection.

Isolate this Patient 28

slide-29
SLIDE 29

PCRs, Immunity Duration, and Possible Repeat Infections…

On the topic of repeat PCR testing…

  • One thing we want to emphasize is that this topic is in rapid

evolution and that our guidance will almost certainly change as we learn more in coming weeks.

  • We are looking at 6 weeks as a cutoff because it is more cautious

and recognize it may lengthen as we learn more.

29

slide-30
SLIDE 30

PCRs, Immunity Duration, and Possible Repeat Infections…

What we know:

  • Isolation of live virus immediately following recovery is extremely rare and

transmission from a recovered patient has not been reported.

  • Immunity immediately following infection is likely (and is the basis of recovery)

but its duration and its correlation with antibody is not known.

  • Immunity to other human coronavirus may be short lived and reinfection with

community associated coronaviruses occurs frequently within a year of initial infection.

30

slide-31
SLIDE 31

PCRs, Immunity Duration, and Possible Repeat Infections…

What we know:

  • Virus detection by PCR can persist in recovered patient for weeks.
  • We would not generally recommend testing for the six weeks following a

positive PCR and recovery, and would disregard any positive results obtained before then.

  • While there may be limited circumstances to use a test‐based clearance strategy, it

is likely to result in longer isolation and may be logistically difficult.

31

slide-32
SLIDE 32

PCRs, Immunity Duration, and Possible Repeat Infections…

CDC & MDPH Guidance around this issue:

  • CDC guidance is that positive PCR results in a symptomatic patient beyond 6

weeks from completing isolation should be interpreted as possible reinfection.

  • A cautious approach to asymptomatic individuals with a positive PCR result

would be to treat them as cases and isolate accordingly. Complex situations may require consultation with an ID specialist. CDC FAQ updated June 4:

https://www.cdc.gov/coronavirus/2019‐ncov/hcp/faq.html#Patients‐with‐Persistent‐or‐Recurrent‐Positive‐Tests

MDPH Updated Testing Guidance July 3:

https://www.mass.gov/doc/covid‐19‐testing‐guidance/download

32

slide-33
SLIDE 33

PCRs, Immunity Duration, and Possible Repeat Infections…

Our Approach to this issue:

  • While we do not believe that recovered individuals with new PCR‐positive

results > 6 weeks after recovery are likely to be infectious, out of an abundance

  • f caution, MA is taking a cautious approach, especially if they are likely to be in

contact with high‐risk individuals, until further data are provided to better understand length of immunity.

Isolate & Interview these Patients 33

slide-34
SLIDE 34

Previous (PCR+ lab): Confirmed Cases:

Summary of Testing after Recovery:

Previous Confirmed Cases (PCR+ lab reported): If these individuals have met criteria for exiting isolation based upon a symptom‐based strategy, additional testing is not recommended.

  • Disregard any additional positive tests up until 6 weeks after exiting isolation.
  • Q. Is there a timeframe after primary symptom onset & recovery

where additional +PCRs WOULD require isolation and quarantine regardless of symptoms?

  • A. Yes. 6 weeks after recovery (exiting isolation).

34

slide-35
SLIDE 35

Previous (PCR+ lab): Confirmed Cases:

  • Q. Do previously confirmed cases need to quarantine if identified as

a contact at a later point?

  • A. Yes if exposed > 6 weeks after exiting isolation.
  • Q. Should previously recovered cases isolate and be tested via PCR if

symptoms recur at a later date?

  • A. Yes
  • Q. If positive, would we do contact tracing based upon new onset dates

and exposure?

  • A. Yes

35

slide-36
SLIDE 36

Previous (Serology+ lab): Probable Cases:

Previously Serology (antibody) Positive Probable Cases (negative PCR

  • r no PCR on record):
  • Q. Previously serology positive with new symptoms – should they

isolate and test via PCR?

  • A. Yes
  • If PCR+, we do contact tracing based upon new onset dates and exposure.
  • They would be reclassified as a CONFIRMED case because this is their first positive

PCR.

  • Q. Should Probable cases later identified as contacts quarantine

(and retest with PCR per recommendation for contacts)?

  • A. Yes
  • If PCR+, follow‐up for isolation and contact tracing accordingly.

36

slide-37
SLIDE 37

PCRs, Immunity Duration, and Possible Repeat Infections…

Let’s summarize what we just said:

  • Immunity immediately following infection is likely (and is the basis of recovery)

but its duration and its correlation with antibody is not known.

  • CDC states: ”If the positive test occurs more than 6‐8 weeks after the person

has completed their most recent isolation, clinicians and public health authorities should consider the possibility of reinfection.”

  • Massachusetts: We are looking at a 6 week cutoff from recovery (exiting

isolation) because it is a cautious cutoff and we may lengthen it as we learn more.

37

slide-38
SLIDE 38

This is Official Guidance now.

  • Old probable and confirmed cases that are identified as new contacts >6 weeks

after recovery: recommend new quarantine at this time.

  • New PCR+ cases (>6 wks after recovery) should be isolated and interviewed. The

information you obtain in these interviews will help inform the big questions on duration of immunity and if patients can get COVID‐19 again.

  • There is no good evidence supporting or refuting the possibility of reinfection with SARS‐

CoV2.

  • Key Points:
  • Don’t run back to retrospective cases at this point to look for newer PCR labs.
  • If you identify new PCR+ labs >6 weeks after a confirmed case recovered, we want to

interview and isolate.

  • Quarantine old cases named as new contacts >6wks after recovery.

38

slide-39
SLIDE 39

Your Questions: Cases who Travel

  • Q. What exact information do we need to gather if someone has traveled to

another state the 14 days before symptom onset?

  • A. Asking about the 14 days prior to symptom onset is really geared towards

identifying where your case might have been exposed, although this is less critical information than WHOM your confirmed case might have exposed while infectious.

  • This can provide some background and context to your investigation & interview, but is less
  • f a priority at this time.
  • Focus on 2 days prior to symptom onset, as that is when your case became infectious.
  • Any travel during those two days and forward should be assessed for possible exposures.
  • Any flights while infectious? We want to do a notification for this.

39

slide-40
SLIDE 40

Flights & Cruises While Infectious

Key Demographic Data Needed:

  • Case Name
  • Date of Birth
  • Full address
  • Clinical Info:
  • Symptom Onset Date & Specific

Symptoms

Travel Information:

  • Airline or cruise company,
  • Flight number,
  • Seat or cabin number,
  • Departure and arrival locations and

times,

  • Reason for travel and if they

traveled alone or with others.

If your confirmed or probable case traveled while infectious and may have exposed others via airplane or maritime vessel (cruise or cargo):

  • 1. Update MAVEN notes
  • 2. Call Epi program so MDPH can notify the Quarantine Station.
  • 3. LBOH – please do not call the Quarantine Station Yourself.

Do the best you can. Travel dates & flight numbers are key even if you don’t have seat number.

40

slide-41
SLIDE 41

Close Contact Definition

Close contact is defined as:

a) Being less than 6 feet from a confirmed or clinically diagnosed COVID‐19 case for at least 10‐15 minutes, while the case was symptomatic or within the 48 hours before symptom onset. Close contact can occur anywhere. Examples include caring for, living with, visiting, or sharing a healthcare waiting area or room with a confirmed or clinically diagnosed COVID‐19 case. OR b) Having direct contact with infectious secretions of a confirmed or clinically diagnosed COVID‐19 case (e.g., being coughed on) while not wearing recommended personal protective equipment or PPE (e.g., gown, gloves, facemask, eye protection).

41

slide-42
SLIDE 42

Your Questions: School Exposures

  • Q. Please discuss the return to school guidelines and the 3 foot distancing.
  • “We encourage districts and schools to aim for six feet of distance between

individuals where feasible. At the same time, a minimum physical distance of three feet has been established when combined with the other measures

  • utlined in this list of safety requirements. Because of the reduced

susceptibility in children and lower apparent rates of transmission, establishing a minimum physical distance of three feet is informed by evidence and balances the lower risk of COVID‐19 transmission and the overarching benefits of in‐ person school.”

  • Key information to note: We would still be using 6 ft indicators for identifying

close contacts if there was an exposure in a school facility.

42

slide-43
SLIDE 43

Your Questions: Social Gatherings

  • Q. Please Discuss a Private Social Gathering Exposure.
  • A. At a private social gathering, we would still utilize a definition of close contact.
  • Did the case have close contact with guests?
  • Did they sit together?
  • Were they inside or outside?
  • Was the case passing out food/serving drinks?
  • Is it possible to have attended a social gathering and not have exposed others?
  • Yes. But you need to delve deeper into the details of the event and your case’s activities at that time.
  • Maybe there are clearly identifiable CLOSE CONTACTS that should be prioritized and notified (and should

quarantine). There may also be a separate list of guests that would appreciate and benefit from an

  • utreach.
  • Encourage the case to send a quick FYI to guests or offer to do a notification for them.

“We want to let you know that someone who attended this event later tested positive for COVID‐19. While you have not been specifically identified as a close contact (which is good!), the individual wanted to make sure you knew about this event and had the opportunity ask any follow‐up questions you might have and be linked to public health resources as needed.”

43

slide-44
SLIDE 44

Your Questions: Social Gatherings

A Note on Mask Wearing:

  • Cloth mask wearing is a risk reduction tool, but does not mean no exposure occurred.

The hope would be that masks reduced the spread of respiratory droplets while two individuals are in close contact, but the contact is still a close contact if it meets our definition.

  • A close contact that wore a cloth mask would still need to quarantine. A confirmed

case wearing a cloth mask could still expose others through close contact.

  • Cloth masks reduce risk but do not prevent exposure completely.

44

slide-45
SLIDE 45

Your Questions: Children

  • Q. If a parent is on quarantine should the children stay with the healthy

parent? What if a parent starts developing symptoms?

  • A. Yes, if possible, anyone in quarantine should try to limit exposure with others,

particularly household members if it can be managed. This will reduce the likelihood

  • f continued spread should the quarantined parent later becomes a case. This would

be a best practice, but we all understand this may be difficult.

  • As soon as the quarantined parent begins to develop symptoms, you should treat them

as a suspect case and they should immediately seek testing/clinical assessment, isolate from others, and their household contacts will need to begin official

  • quarantine. If the children cannot fully separate from the case, they must remain in

quarantine until the case recovers and is no longer infectious, then their final 14 days

  • f quarantine countdown begins.

45

slide-46
SLIDE 46

Your Questions: Testing of Contacts

  • Q. How long after an exposure to COVID‐19 can a person reliably test for it ? Is it

better to test a couple days later to be accurate?

  • A. I haven’t found the exact answer to this question. Some judgement is needed.
  • The virus’s incubation period is around 5 to 7 days, but it can be up to 14 days.
  • Testing only identifies the presence of virus at the time of the test. It is possible that

someone can test negative because they are very early in their infection when their sample is collected. In such situations, they could test positive later and transmit the virus to

  • thers.
  • State guidance doesn’t give an exact timeframe following exposure.
  • If symptomatic, get tested right away.
  • If asymptomatic, get tested as soon as you can after being notified. But a negative test still means

you have to complete the 14 day quarantine period.

  • If you develop symptoms AFTER your first negative test, get tested again.
  • If you stay asymptomatic for the duration of quarantine, no additional testing is needed.

46

slide-47
SLIDE 47

Your Questions: Testing of Contacts

  • Q. If a Contact or traveler tests negative for COVID‐19, do they still have to

quarantine?

  • A. 100% yes.
  • Anyone in quarantine should complete their 14 days regardless of a

negative test earlier in that 14 day period.

  • So if a contact tests negative on Day 7, that still must stay in Quarantine the full 14
  • days. They could still develop illness at a later date in that 14 day period.
  • Negative COVID‐19 testing DOES NOT release you from Quarantine Early.

47

slide-48
SLIDE 48

Your Questions: CTC & Holidays

  • Q. Does the CTC take our cases on holiday weekends or holidays such as the
  • ne we just had?
  • A. Yes.
  • If you do not want the CTC to take new confirmed events over weekends and holidays,

someone needs to log into MAVEN on those days and mark assistance requested = No.

48

slide-49
SLIDE 49

Your Questions: Travel Quarantine

  • Q. What is the latest guidance on quarantine for travelers (or returning travelers) to MA?
  • A. All travelers arriving to Massachusetts – including Massachusetts residents returning

home – are instructed to self‐quarantine for 14 days.

  • (July 1) Except travelers from the following arriving in MA do not need to self‐quarantine for 14 days:
  • Rhode Island,
  • Connecticut,
  • Vermont,
  • New Hampshire,
  • Maine,
  • New York, and
  • New Jersey
  • In addition, workers designated by the federal government as essential critical infrastructure workers

are exempt from the directive to self‐quarantine for 14 days if traveling to Massachusetts for work purposes.

  • All persons are instructed not to travel to Massachusetts if they are displaying symptoms of COVID‐

19.

  • Directive Language: https://www.mass.gov/info‐details/travel‐information‐related‐to‐covid‐

19#:~:text=All%20travelers%20arriving%20to%20Massachusetts,in%20Massachusetts%20are%20exempt%20from

49

slide-50
SLIDE 50

50